Camlin Fine Sciences (NSE:CAMLINFINE) Liabilities-to-Assets : (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:CAMLINFINE Camlin Fine Sciences Ltd NSE:CAMLINFINE
60 GF Score
Price ₹97.28
GF Value ₹143.19
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Camlin Fine Sciences Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Camlin Fine Sciences's Total Liabilities for the quarter that ended in Jun. 2026 was ₹ Mil. Camlin Fine Sciences's Total Assets for the quarter that ended in Jun. 2026 was ₹ Mil.


Camlin Fine Sciences  (NSE:CAMLINFINE) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Camlin Fine Sciences Liabilities-to-Assets Related Terms


Camlin Fine Sciences Liabilities-to-Assets Historical Data

* Premium members only.

The historical data trend for Camlin Fine Sciences's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Camlin Fine Sciences Liabilities-to-Assets Chart

Camlin Fine Sciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Liabilities-to-Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.58 0.60 0.56 0.57 0.57

Camlin Fine Sciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.58 - 0.57 -

NSE:CAMLINFINE vs LIN, SHW, ECL: Liabilities-to-Assets Comparison

For the Specialty Chemicals subindustry, Camlin Fine Sciences's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Camlin Fine Sciences Liabilities-to-Assets vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Camlin Fine Sciences's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Camlin Fine Sciences's Liabilities-to-Assets falls into.


NSE:CAMLINFINE
60GF Score
Camlin Fine Sciences Ltd NSE:CAMLINFINE
Liabilities-to-Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Camlin Fine Sciences Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Camlin Fine Sciences's Liabilities-to-Assets Ratio for the fiscal year that ended in Mar. 2026 is calculated as:

Liabilities-to-Assets (A: Mar. 2026 )=Total Liabilities/Total Assets
=13230.962/23239.028
=0.57

Camlin Fine Sciences's Liabilities-to-Assets Ratio for the quarter that ended in Jun. 2026 is calculated as

Liabilities-to-Assets (Q: Jun. 2026 )=Total Liabilities/Total Assets
=/
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Camlin Fine Sciences (NSE:CAMLINFINE) Overvalued in 2026?

Based on GuruFocus' analysis, Camlin Fine Sciences stock appears to be undervalued. The current stock price of ₹97.28 is trading 32.1% below its estimated GF Value™ of ₹143.19. GuruFocus considers Camlin Fine Sciences to be Significantly Undervalued.

Key valuation signals for NSE:CAMLINFINE:

  • Liabilities-to-Assets:
  • GF Value™: ₹143.19 vs. price of ₹97.28 (32.1% below fair value)
  • GF Score™: 60/100 with 5 warning signs

No single metric tells the full story. See the NSE:CAMLINFINE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Camlin Fine Sciences Business Description

Other Exchanges 532834:India
Address CST Road, Kalina, Floor 2 to 5, In GS Point, Santacruz East, Mumbai, MH, IND, 400 098
Camlin Fine Sciences Ltd is engaged in research, development, manufacturing, commercializing, and marketing of specialty chemicals and blends. These chemicals are used in food, feed, animal and pet nutrition and industrial products. The Company has only one reportable segment, namely, Speciality Chemicals. The company's product portfolio consists of Shelf life solutions, Aroma ingredients, Performance chemicals and Health & Wellness. Shelf life extension solutions include antioxidant solutions which are used to increase the shelf life of oils and. Aroma vertical includes a production of Vanillin and Ethyl Vanillin. Performance Chemicals consist of Guaiacol, Veratrole, TBC, and MEHQ and are used in sectors such as food flavoring, pharmaceuticals intermediate fragrance industry.
60GF Score

Get the complete analysis for NSE:CAMLINFINE

Liabilities-to-Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹97.28
Price
₹143.19
GF Value